D68.8
Other specified coagulation defects
Clinical Classification Guidelines
Inclusion Terms
- COVID-19 associated coagulopathy
Excludes Type 1
- hemorrhagic disease of newborn (P53)
Code Also
- , if applicable, associated condition
Medical Intelligence & Overview
Other specified coagulation defects, classified under ICD-10 code D68.8, refer to a group of bleeding or clotting disorders that do not fit into more common categories but involve abnormalities in blood clotting mechanisms. These conditions can lead to increased risk of bleeding or clot formation, affecting overall health and requiring careful management. A notable example includes COVID-19 associated coagulopathy, a complication observed in some individuals infected with the coronavirus.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting clotting factors not classified under specific inherited disorders Acquired conditions such as liver disease impairing the synthesis of clotting factors Medications like anticoagulants that interfere with blood clotting Autoimmune disorders that produce antibodies against clotting components Infections, notably COVID-19, which can disrupt the balance of blood coagulation
Key Symptoms: Unusual bleeding, such as excessive bruising or bleeding from gums or nose Prolonged bleeding after injuries or surgeries Unexplained blood clots leading to swelling, pain, or shortness of breath Heavy menstrual periods Signs of internal bleeding like abdominal pain or blood in stool or urine In severe cases, symptoms may include dizziness, weakness, or rapid heartbeat due to blood loss or clot-related complications
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory testing. Blood tests such as coagulation profiles, including prothrombin time (PT), activated partial thromboplastin time (aPTT), platelet count, and specific assays for clotting factors, are essential. Additional tests might include imaging to identify blood clots or bleeding sites. Medical history, including recent infections or medication use, is also reviewed to identify underlying causes.
Treatment Protocols: Treatment strategies depend on the specific abnormality and its severity. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is D68.8 a billable ICD-10 code?
Yes, D68.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D68.8?
Clinical documentation must specify the nature of Other specified coagulation defects and any associated comorbidities for accurate reporting.
Cite this Clinical Reference